Basic Information
| RNALocate ID: | RLID:01001379 |
| RNA Symbol: | hsa-miR-30a-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-30a |
| RNA ID: | miRBase:MIMAT0000087 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001378 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001380 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001381 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001382 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001383 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000903 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11000904 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000905 | Exosome | Brain tissue | 23382797 |
| RLID:11000906 | Exosome | Plasma | 23663360 |
| RLID:11000907 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000908 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11000909 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000910 | Microvesicle | Plasma | 23077538 |
| RLID:11000911 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000912 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000913 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:21000215 | Cytoplasmic stress granule | HeLa cells | 28488892 |
| RLID-D:11000023 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Epithelial cells|Kidney tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000286 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-36677 |
| MNDR | hsa-miR-30a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-36678 |
| MNDR | hsa-miR-30a-5p | Colorectal adenoma | MNDR-E-MI-36679 |
| MNDR | hsa-miR-30a-5p | Oral squamous cell carcinoma | MNDR-E-MI-36680 |
| MNDR | hsa-miR-30a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-36681 |
| MNDR | hsa-miR-30a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-36682 |
| MNDR | hsa-miR-30a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-36683 |
| MNDR | hsa-miR-30a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-36684 |
| MNDR | hsa-miR-30a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-36685 |
| MNDR | hsa-miR-30a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-36686 |
| MNDR | hsa-miR-30a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-36687 |
| MNDR | hsa-miR-30a-5p | Triple negative breast cancer | MNDR-E-MI-36688 |
| MNDR | hsa-miR-30a-5p | Lupus nephritis | MNDR-E-MI-36689 |
| MNDR | hsa-miR-30a-5p | Thyroid carcinoma anaplastic | MNDR-E-MI-36690 |
| MNDR | hsa-miR-30a-5p | Dermatomyositis | MNDR-E-MI-36691 |
| MNDR | hsa-miR-30a-5p | Prostate cancer | MNDR-E-MI-36692 |
| MNDR | hsa-miR-30a-5p | Gastric cancer | MNDR-E-MI-36693 |
| MNDR | hsa-miR-30a-5p | Gastric lymphoma | MNDR-E-MI-36694 |
| MNDR | hsa-miR-30a-5p | Alzheimer disease | MNDR-E-MI-36695 |
| MNDR | hsa-miR-30a-5p | Bladder cancer | MNDR-E-MI-36696 |
| MNDR | hsa-miR-30a-5p | Esophageal carcinoma | MNDR-E-MI-36697 |
| MNDR | hsa-miR-30a-5p | Sarcoma | MNDR-E-MI-36698 |
| MNDR | hsa-miR-30a-5p | Duchenne muscular dystrophy | MNDR-E-MI-36699 |
| MNDR | hsa-miR-30a-5p | Seizures | MNDR-E-MI-36700 |
| MNDR | hsa-miR-30a-5p | Head and neck cancer | MNDR-E-MI-36701 |
| MNDR | hsa-miR-30a-5p | Leukemia | MNDR-E-MI-36702 |
| MNDR | hsa-miR-30a-5p | Huntington disease | MNDR-E-MI-36703 |
| MNDR | hsa-miR-30a-5p | Chorea | MNDR-E-MI-36704 |
| MNDR | hsa-miR-30a-5p | Cardiovascular disease | MNDR-E-MI-36705 |
| MNDR | hsa-miR-30a-5p | Moyamoya disease | MNDR-E-MI-36706 |
| MNDR | hsa-miR-30a-5p | Brain cancer | MNDR-E-MI-36707 |
| MNDR | hsa-miR-30a-5p | Uterine fibroid | MNDR-E-MI-36708 |
| MNDR | hsa-miR-30a-5p | Lung cancer | MNDR-E-MI-36709 |
| MNDR | hsa-miR-30a-5p | Down syndrome | MNDR-E-MI-36710 |
| MNDR | hsa-miR-30a-5p | Parkinson disease | MNDR-E-MI-36711 |
| MNDR | hsa-miR-30a-5p | Colon carcinoma | MNDR-E-MI-36712 |
| MNDR | hsa-miR-30a-5p | Basal-like breast cancer | MNDR-E-MI-36713 |
| MNDR | hsa-miR-30a-5p | Squamous cell carcinoma | MNDR-E-MI-36714 |
| MNDR | hsa-miR-30a-5p | Thyroid cancer | MNDR-E-MI-36715 |
| MNDR | hsa-miR-30a-5p | Pituitary neoplasms | MNDR-E-MI-36716 |
| MNDR | hsa-miR-30a-5p | Pancreatic cancer | MNDR-E-MI-36717 |
| MNDR | hsa-miR-30a-5p | Melanoma | MNDR-E-MI-36718 |
| MNDR | hsa-miR-30a-5p | Rectum adenocarcinoma | MNDR-E-MI-36719 |
| MNDR | hsa-miR-30a-5p | Nephroblastoma | MNDR-E-MI-36720 |
| MNDR | hsa-miR-30a-5p | Colon cancer | MNDR-E-MI-36721 |
| MNDR | hsa-miR-30a-5p | Ischemic attack transient | MNDR-E-MI-36722 |
| MNDR | hsa-miR-30a-5p | Colon adenocarcinoma | MNDR-E-MI-36723 |
| MNDR | hsa-miR-30a-5p | Multiple sclerosis | MNDR-E-MI-36724 |
| MNDR | hsa-miR-30a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-36725 |
| MNDR | hsa-miR-30a-5p | Familial ovarian cancer | MNDR-E-MI-36726 |
| MNDR | hsa-miR-30a-5p | Acromegaly | MNDR-E-MI-36727 |
| MNDR | hsa-miR-30a-5p | Prostate adenocarcinoma | MNDR-E-MI-36728 |
| MNDR | hsa-miR-30a-5p | Carcinoma ductal breast | MNDR-E-MI-36729 |
| MNDR | hsa-miR-30a-5p | Balkan nephropathy | MNDR-E-MI-36730 |
| MNDR | hsa-miR-30a-5p | Glioblastoma | MNDR-E-MI-36731 |
| MNDR | hsa-miR-30a-5p | Glioma | MNDR-E-MI-36732 |
| MNDR | hsa-miR-30a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-36733 |
| MNDR | hsa-miR-30a-5p | Temporal lobe epilepsy | MNDR-E-MI-36734 |
| MNDR | hsa-miR-30a-5p | Osteosarcoma | MNDR-E-MI-36735 |
| MNDR | hsa-miR-30a-5p | Liposarcoma | MNDR-E-MI-36736 |
| MNDR | hsa-miR-30a-5p | Carotid artery disease | MNDR-E-MI-36737 |
| MNDR | hsa-miR-30a-5p | Inclusion body myositis | MNDR-E-MI-36738 |
| MNDR | hsa-miR-30a-5p | Meningioma | MNDR-E-MI-36739 |
| MNDR | hsa-miR-30a-5p | Liver cancer | MNDR-E-MI-36740 |
| MNDR | hsa-miR-30a-5p | Uterine cancer | MNDR-E-MI-36741 |
| MNDR | hsa-miR-30a-5p | Cervical adenocarcinoma | MNDR-E-MI-36742 |
| MNDR | hsa-miR-30a-5p | Gastric adenocarcinoma | MNDR-E-MI-36743 |
| MNDR | hsa-miR-30a-5p | Pituitary adenoma | MNDR-E-MI-36744 |
| MNDR | hsa-miR-30a-5p | Lung squamous cell carcinoma | MNDR-E-MI-36745 |
| MNDR | hsa-miR-30a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-36746 |
| MNDR | hsa-miR-30a-5p | Lung adenocarcinoma | MNDR-E-MI-36747 |
| MNDR | hsa-miR-30a-5p | Adrenocortical cancer | MNDR-E-MI-36748 |
| MNDR | hsa-miR-30a-5p | Thyroid carcinoma | MNDR-E-MI-36749 |
| MNDR | hsa-miR-30a-5p | Bladder urothelial carcinoma | MNDR-E-MI-36750 |
| MNDR | hsa-miR-30a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-36751 |
| MNDR | hsa-miR-30a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-36752 |
| MNDR | hsa-miR-30a-5p | Carcinoma renal cell | MNDR-E-MI-36753 |
| MNDR | hsa-miR-30a-5p | Papillary renal cell carcinoma | MNDR-E-MI-36754 |
| MNDR | hsa-miR-30a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-36755 |
| MNDR | hsa-miR-30a-5p | Large cell carcinoma | MNDR-E-MI-36756 |
| MNDR | hsa-miR-30a-5p | Biliary tract cancer | MNDR-E-MI-36757 |
| MNDR | hsa-miR-30a-5p | Cholangiocarcinoma | MNDR-E-MI-36758 |
| MNDR | hsa-miR-30a-5p | Esophageal cancer | MNDR-E-MI-36759 |
| MNDR | hsa-miR-30a-5p | Prolactinoma | MNDR-E-MI-36760 |
| MNDR | hsa-miR-30a-5p | Lung small cell carcinoma | MNDR-E-MI-36761 |
| MNDR | hsa-miR-30a-5p | Schizophrenia | MNDR-E-MI-36762 |
| MNDR | hsa-miR-30a-5p | Variant creutzfeldt-jakob disease | MNDR-E-MI-36763 |
| MNDR | hsa-miR-30a-5p | Synovial sarcoma | MNDR-E-MI-36764 |
| MNDR | hsa-miR-30a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-36765 |
| MNDR | hsa-miR-30a-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-36766 |
| MNDR | hsa-miR-30a-5p | Breast invasive carcinoma | MNDR-E-MI-36767 |
| MNDR | hsa-miR-30a-5p | Hepatocellular carcinoma | MNDR-E-MI-36768 |
| MNDR | hsa-miR-30a-5p | Familiar ovarian carcinoma | MNDR-E-MI-36769 |
| MNDR | hsa-miR-30a-5p | B-cell lymphoma | MNDR-E-MI-36770 |
| MNDR | hsa-miR-30a-5p | Rheumatoid arthritis | MNDR-E-MI-36771 |
| MNDR | hsa-miR-30a-5p | T-cell leukemia | MNDR-E-MI-36772 |
| MNDR | hsa-miR-30a-5p | Abdominal aortic aneurysm | MNDR-E-MI-36773 |
| MNDR | hsa-miR-30a-5p | Osteoarthritis | MNDR-E-MI-36774 |
| MNDR | hsa-miR-30a-5p | Chronic myelogenous leukemia | MNDR-E-MI-36775 |
| MNDR | hsa-miR-30a-5p | Hodgkin lymphoma | MNDR-E-MI-36776 |
| MNDR | hsa-miR-30a-5p | Burkitt lymphoma | MNDR-E-MI-36777 |
| MNDR | hsa-miR-30a-5p | Tonsil cancer | MNDR-E-MI-36778 |
| MNDR | hsa-miR-30a-5p | Neuromyelitis optica | MNDR-E-MI-36779 |
| MNDR | hsa-miR-30a-5p | Colorectal cancer | MNDR-E-MI-36780 |
| MNDR | hsa-miR-30a-5p | Nasopharynx carcinoma | MNDR-E-MI-36781 |
| MNDR | hsa-miR-30a-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-36782 |
| MNDR | hsa-miR-30a-5p | Cardiomegaly | MNDR-E-MI-36783 |
| MNDR | hsa-miR-30a-5p | Nasopharyngeal cancer | MNDR-E-MI-36784 |
| MNDR | hsa-miR-30a-5p | Prostatic neoplasms | MNDR-E-MI-36785 |
| MNDR | hsa-miR-30a-5p | Pseudorabies | MNDR-E-MI-36786 |
| MNDR | hsa-miR-30a-5p | Sleep deprivation | MNDR-E-MI-36787 |
| MNDR | hsa-miR-30a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-36788 |
| MNDR | hsa-miR-30a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-36789 |
| MNDR | hsa-miR-30a-5p | Venous thromboembolism | MNDR-E-MI-36790 |
| MNDR | hsa-miR-30a-5p | Stroke lacunar | MNDR-E-MI-36791 |
| MNDR | hsa-miR-30a-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-36792 |
| MNDR | hsa-miR-30a-5p | Breast cancer her3+ negative | MNDR-E-MI-36793 |
| MNDR | hsa-miR-30a-5p | Duke A | MNDR-E-MI-36794 |
| MNDR | hsa-miR-30a-5p | Glomerular disease | MNDR-E-MI-36795 |
| MNDR | hsa-miR-30a-5p | Low grade dysplastic nodule | MNDR-E-MI-36796 |
| MNDR | hsa-miR-30a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-36797 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABL1 | Homo sapiens | RR00026978 |
TOP